1. Home
  2. POST vs GRFS Comparison

POST vs GRFS Comparison

Compare POST & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Post Holdings Inc.

POST

Post Holdings Inc.

N/A

Current Price

$101.87

Market Cap

5.0B

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.03

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POST
GRFS
Founded
1895
1940
Country
United States
Spain
Employees
13180
25247
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.8B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
POST
GRFS
Price
$101.87
$8.03
Analyst Decision
Buy
Hold
Analyst Count
6
2
Target Price
$127.33
$10.15
AVG Volume (30 Days)
594.7K
647.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.77%
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$8,158,100,000.00
N/A
Revenue This Year
$4.94
$5.33
Revenue Next Year
$0.42
$6.50
P/E Ratio
$59.44
$18.67
Revenue Growth
2.97
N/A
52 Week Low
$95.07
$6.19
52 Week High
$119.85
$11.14

Technical Indicators

Market Signals
Indicator
POST
GRFS
Relative Strength Index (RSI) 37.62 30.37
Support Level $96.16 $7.64
Resistance Level $102.05 $9.11
Average True Range (ATR) 2.07 0.30
MACD -0.72 -0.11
Stochastic Oscillator 3.43 4.38

Price Performance

Historical Comparison
POST
GRFS

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: